0001387131-21-009803.txt : 20211006 0001387131-21-009803.hdr.sgml : 20211006 20211006164829 ACCESSION NUMBER: 0001387131-21-009803 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20211001 FILED AS OF DATE: 20211006 DATE AS OF CHANGE: 20211006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Desai Meera J. CENTRAL INDEX KEY: 0001886559 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36242 FILM NUMBER: 211310206 MAIL ADDRESS: STREET 1: 1682 EL CAMINO REAL STREET 2: STE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 997-2400 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950615 3 1 mdesai-form3_100121.xml INITIAL STATEMENT OF BENEFICIAL OWNERSHIP X0206 3 2021-10-01 1 0000887247 Adamis Pharmaceuticals Corp ADMP 0001886559 Desai Meera J. C/O ADAMIS PHARMACEUTICALS CORPORATION 11682 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 1 0 0 0 Exhibit 24 - Power of Attorney /s/ David C. Benedicto, as Attorney-in-Fact 2021-10-06 EX-24 2 ex24.htm POWER OF ATTORNEY

Adamis Pharmaceuticals Corporation Form 3

Exhibit 24

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of David C. Benedicto and Dennis J. Carlo, or either of them signing singly and with full power of substitution, as the undersigned’s true and lawful attorney-in-fact (“Attorney”) to:

(1)

to the extent necessary, prepare, execute in the undersigned’s name and on behalf of the undersigned, and submit to the U.S. Securities and Exchange Commission (the “SEC”), a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC, and execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Adamis Pharmaceuticals Corporation (the “Company”), Forms 3, 4, and 5, and any amendments thereto, in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2)

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3)

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such Attorney, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such Attorney on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such Attorney may approve in such Attorney’s discretion.

The undersigned hereby grants to each Attorney full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such Attorney, or such Attorney’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing Attorney, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. The Attorneys and the Company shall not be liable for any error of judgment or for any act done or omitted or for any mistake of fact or law. The undersigned agrees to indemnify each Attorney for and to hold the Attorney free from and harmless against any and all loss, claim, damage, liability or expense incurred by or on behalf of the Attorney arising out of or in connection with acting as Attorney under this Power of Attorney, as well as the cost and expense of defending against any claim of liability hereunder, and not due to the Attorney’s own gross negligence or bad faith. The undersigned agrees that the Attorney may consult with counsel of their choice (which may but need not be counsel for the Company) and the Attorney shall have full and complete authorization and protection for any action taken or suffered by the Attorney, or any of them hereunder, in good faith and in accordance with the opinion of such counsel.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing Attorney.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 1^st day of October, 2021.

	/s/ Meera J. Desai

	Meera J. Desai